Studying heart changes after tricuspid valve replacement
Part of Heart & circulation clinical trials.
This study looks at how the heart adjusts after a procedure to replace the tricuspid valve (the valve between the right upper and lower heart chambers). It focuses on patients who need medication to support their blood pressure within 24 hours after the procedure, to better understand and manage this unstable period.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a tricuspid valve replacement with a specific type of valve called the Evoque system (or another valve used under special permission).
- Within 24 hours after the procedure, you needed medicine to raise your blood pressure because your heart was not pumping steadily.
- This drop in blood pressure was not caused by a major problem during the procedure, like bleeding or fluid around the heart.
- You did not receive blood pressure medicine just as a routine part of recovery or to support the right side of your heart without signs of poor blood flow.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new, less invasive way to replace the tricuspid valve (the valve between the right upper and lower heart chambers) in people with severe leakage. The valve is delivered through a vein in the neck or leg, avoiding open-heart surgery.
This trial tests a new catheter-based device to replace your tricuspid valve without open-heart surgery. It's for people with severe tricuspid regurgitation who are at high risk for surgery.
This trial tests a new device called Laplace TTVR to replace a leaky tricuspid valve in the heart without open surgery. It is for people with severe symptoms despite medical treatment.
This trial tests a new, less invasive valve device (TricValve) for people with severe tricuspid regurgitation who are not good candidates for open-heart surgery. It aims to see if this device can help your heart pump better and improve your symptoms.
This study tracks how well new heart valve replacement and repair devices work after they're implanted. Researchers will monitor your health over time to ensure the device is safe and functioning properly.
This trial is testing a new, less-invasive device to fix the tricuspid valve in the heart for people with severe leakage. It may be an option if you are not a good candidate for traditional open-heart surgery and have tried other treatments.
Hear when a new Tricuspid Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.